Acquires exclusive rights to manufacture, market and distribute Rivotril in India Adds a clonazepam Textbook brand with strong clinical legacy and specialist recall Strengthens Mankind Pharma’s strategic focus on chronic and CNS therapies Creates a platform for future expansion through potential line extensions Mankind Pharma
Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South Asia Represents a major step in the mission of Actimed to bring the first globally approved cancer cachexia product to patients in need Actimed Therapeutics Ltd (“Actimed”), a
Mankind Pharma Ltd on Monday announced that it has invested in a clinical stage specialty pharmaceutical company, Actimed Therapeutics Ltd, UK. Actimed Therapeutics is focused on bringing innovation to the treatment of cancer cachexia, an unmet medical need for cancer patients, and other muscle wasting
